FASING vs PHARMENA
Side-by-side comparison of key ratios for FASING and PHARMENA.
Last updated: Source: ESEF / GPW
| Metric | FASING FSG | PHARMENA PHR |
|---|---|---|
| P/E | 2.7 | — |
| EPS (TTM) | 5.23 | -0.14 |
| Dividend yield | — | — |
| Market cap | 44 mln | 43 mln |
This information is provided for informational purposes only and does not constitute investment advice or a recommendation. Listings describe companies by the stated criteria and are not an inducement to buy or sell any financial instrument. Verify figures against official sources before making any investment decision.